This inventor holds 1 USPTO granted patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hui Li - Innovator in Pharmaceutical Development
Introduction
Hui Li is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing methods for treating diseases related to mutant KIT and PDGFRA.
Latest Patents
Hui Li holds 1 patent for his work titled "Synthetic methods and intermediates for producing compounds for treating KIT- and PDGFRA-mediated diseases." This patent provides methods and intermediates for making Compound A or a pharmaceutical salt thereof, which are useful in treating various diseases and conditions.
Career Highlights
Hui Li is currently employed at Blueprint Medicines Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on innovative solutions for complex medical challenges.
Collaborations
Hui collaborates with talented professionals in his field, including Gilles Caillot and Khalid Diker. These partnerships enhance the research and development process, leading to more effective treatments.
Conclusion
Hui Li's contributions to pharmaceutical innovation demonstrate his commitment to improving healthcare through scientific advancements. His work continues to impact the treatment of serious medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile